Compare iShares MSCI Germany (DAX) (EWG) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Moderna, Inc. — how do they compare? iShares MSCI Germany (DAX) trades at $43.83, while Moderna, Inc. trades at $63.7 (market cap $24.18B). The key difference: iShares MSCI Germany (DAX) is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| EWG | MRNA | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $44.56 | $81.80 |
52-Week Low | $38.08 | $22.36 |
Market Cap | — | $24.18B |
Enterprise Value | — | $20.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG trades at $43.87 with no recent price change. Technical indicators show a bullish trend from moving averages, though oscillators are neutral and RSI levels suggest overbought conditions. Recent news highlights European Central Bank policy decisions and German economic reforms influencing market sentiment.
The outlook is cautiously optimistic due to bullish technical signals, but limited fundamental data and overbought RSI levels pose risks. Investors should monitor European economic developments and company-specific financial updates for directional cues amid geopolitical and energy price volatility.
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
